Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 9/25/2023AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space
  • 9/24/2023PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...
  • 9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...
  • 9/21/2023Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...
  • 9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
  • 9/20/2023Everest Medicines Enters into Collaboration and License Agreement with...
  • 9/19/2023Novartis, BeiGene Agree to Terminate Deal for Cancer Drug Candidate
  • 9/18/2023GenScript Expands Range of Reagent Services, Adding Circular RNA and L...
  • 9/15/2023JW Therapeutics and 2Seventy Bio Announce Strategic Partnership to Acc...
  • 9/15/2023Cure Genetics, Frametact to Develop Brain Disease Gene Therapies in $6...
  • 9/13/2023LIB Thera and Hasten Biopharma Announce $325M Strategic Collaboration ...
  • 9/13/2023Clover Biopharma Launches Quadrivalent Influenza Vaccine in Mainland C...
  • 9/13/2023AriBio, Shanghai Pharma to Commercialize Oral Alzheimer's Drug AR1001
  • 9/13/2023Exelixis and Insilico Enter Global Licensing Pact for Anticancer Candi...
  • 9/12/2023Chinese Pharma Companies Expand Foothold in Africa
  • 9/7/2023MSD Plans to Boost New Product Launch and Pharma R&D in China
  • 8/31/2023Financial-related Company News Digest (August 2023)
  • 8/31/2023MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
  • 8/30/2023Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
  • 8/29/2023CanSino to Acquire 10% Stake in Malaysian Vaccine Maker Solution
  • 8/28/2023Chinese Pharma CEOs Emphasize Strategic R&D Selection in Tough Fundrai...
  • 8/28/2023Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
  • 8/25/2023State Council Adopts New Action Plan for High-quality Development of P...
  • 8/25/2023Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
  • 8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
  • 8/24/2023Chinese Consortium Eyes Acquisition of Dominant Polish Pharma Distribu...
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 8/23/2023Chinese and Indonesian Cos Form New Partnerships in Biotech & Healthca...
  • 8/22/2023Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
  • 8/22/2023CSPC, Insilico and XtalPi Sign Strategic Collaboration on AI Innovativ...
  • Page:11/13 Total number of articles:365: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group